The Effects of 10-weeks Pilates Exercise on Pulmonary Function and Quality of Life in Postmenopausal Women (RCT)

The Effects of 10-weeks Pilates Exercise on Pulmonary Function and Quality of Life in Postmenopausal Women With Normal Body Mass Idex: A Randomized Controlled Trial.

This study will investigate the effect of 10-weeks Pilates exercise on pulmonary function and quality of life in postmenopausal women with normal Body mass index

Study Overview

• Status: Recruiting
• Conditions: Post Menopausal
• Intervention / Treatment: Other: diaphragmatic breathing exercises; Other: pilates exercises

Detailed Description

This study is significant because it explores a safe, low-impact, and accessible exercise method that may improve respiratory function and overall quality of life in postmenopausal women. Pilates emphasizes breathing, core strength, and controlled movements, which may be particularly beneficial for women experiencing age-related declines in lung function and physical well-being. The findings can support evidence-based exercise recommendations, promote non-pharmacological interventions, and contribute to improving the health and daily functioning of postmenopausal women.

• Study Type: Interventional
• Enrollment (Estimated): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ayman MAE Mahany, PHD; Phone Number: 0021096614445; Email: a.mahany@meu.edu.jo
• Study Contact Backup: Name: Mohammed MAE Rafaat, PHD; Phone Number: 0021206530584; Email: aymanmila2020@gmail.com

Study Locations

• Jordan
  • Amman, Jordan, 11732
    • Recruiting
    • Ayman Mohammad Abu Elmila Mahany
    • Contact: Ayman MAE Mahany; Email: aymanmila2020@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Postmenopausal women aged 50-60 years.
• Women who suffered from breathing problems
• Women with normal body mass index (BMI) 18 to 25 kg/m².
• Women not related to any other studies.

Exclusion Criteria:

• Comorbidities such as cardiac or chest diseases (critically ill patients).
• Receiving hormone replacement therapy.
• BMI ˃ 25 kg/m² or ˂ 18 kg/m²,
• Age greater than 60 years or less than 50 years,
• Use of sedatives, tranquilizers, or antidepressant medications,
• Musculoskeletal disorders.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: control group; It will consist of 15 postmenopausal women. They will receive diaphragmatic breathing exercises for 5 to 10 minutes in a session, about 3-4 times per day and follow up after 10 weeks	Other: diaphragmatic breathing exercises; is a technique that focuses on deep breathing using the diaphragm rather than shallow chest breaths. It helps improve oxygen intake and promotes relaxation.for 5 to 10 minutes in a session, about 3-4 times per day and follow up after 10 weeks
Experimental: study group; It will consist of 15 postmenopausal women. They will receive diaphragmatic breathing exercises for 5 to 10 minutes in a session, about 3-4 times per day for 10 weeks in addition to pilates exercise for 50-minute per s session for 5 times per week and follow up after 10 weeks	Other: diaphragmatic breathing exercises; is a technique that focuses on deep breathing using the diaphragm rather than shallow chest breaths. It helps improve oxygen intake and promotes relaxation.for 5 to 10 minutes in a session, about 3-4 times per day and follow up after 10 weeks; Other: pilates exercises; low-impact exercise method that focuses on strengthening muscles while improving posture, flexibility, and overall body alignment. It emphasizes controlled movements, proper breathing, and core strength (especially the abdomen, lower back, hips, and pelvis).for 50-minute pers session for 5 times per week and follow up after 10 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Forced Vital Capacity	will be recorded before and after the intervention using a spirometer, and measured in liters	10 weeks
Forced Expiratory Volume	will be recorded before and after the intervention using a spirometer, and measured in liters	10 weeks
Peak Expiratory Flow Rate and measured in liters per seconds	will be recorded before and after the intervention using a spirometer, and measured in liters	10 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of life questionnaire :	SF-12 Health Survey will be used for the assessment of quality of life. It is a brief, 12-question covering eight health domains, including physical functioning, mental health, Score range: Lowest: 0 Highest: 100 Interpretation: 0 = worst health status 100 = best health status pain, and social functioning, yielding Physical (PCS) and Mental (MCS) Component Summary scores	10 weeks

Collaborators and Investigators

• Sponsor: Middle East University
• Investigators: Principal Investigator: Ayman MAE Mahany, Horus University

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2026
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): October 1, 2026

Study Registration Dates

• First Submitted: June 20, 2026
• First Submitted That Met QC Criteria: June 26, 2026
• First Posted (Actual): June 29, 2026

Study Record Updates

• Last Update Posted (Actual): June 29, 2026
• Last Update Submitted That Met QC Criteria: June 26, 2026
• Last Verified: June 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Therapeutics; Physical Therapy Modalities; Exercise Movement Techniques
• Other Study ID Numbers: PT-2026-011

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: No IPD Sharing

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No